Results 141 to 150 of about 1,244 (201)

A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy. [PDF]

open access: yesFuture Oncol
Grivas P   +17 more
europepmc   +1 more source

Club Activity, Study Groups, and Academic Achievement: A Nationwide Study of Japanese Medical Students' Extracurricular Life. [PDF]

open access: yesJ Gen Fam Med
Fujikawa H   +10 more
europepmc   +1 more source

Neural mechanisms and social support for mental health in old age by martial arts exercise. [PDF]

open access: yesFront Psychol
Jiang Y   +11 more
europepmc   +1 more source

The Influence of the Germline <i>HSD3B1</i> Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer. [PDF]

open access: yesCancers (Basel)
Kellen S   +14 more
europepmc   +1 more source

Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after <sup>177</sup>Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes. [PDF]

open access: yesEur Urol Oncol
Raychaudhuri R   +19 more
europepmc   +1 more source

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial. [PDF]

open access: yesJ Clin Oncol
Wang JH   +33 more
europepmc   +1 more source

Pan-Cancer Interrogation of <i>MUTYH</i> Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors. [PDF]

open access: yesJCO Precis Oncol
Paller CJ   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy